Skip to content

Spectroscopic Profiling of Extracellular Vesicles By Resonant Gold Nanostructures in the Infrared

Spectroscopic Profiling of Extracellular Vesicles By Resonant Gold Nanostructures in the Infrared

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06266195
Acronym
PROVEIR_1
Enrollment
64
Registered
2024-02-20
Start date
2023-03-15
Completion date
2025-02-28
Last updated
2024-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vesicle

Keywords

MICROVESCICLES; CIRRHOSIS; HCC; NANOSTRUCTURES.

Brief summary

Extracellular vesicles, due to their ease of extraction and ability to represent the cells from which they originate, have high potential in the field of personalized medicine, especially in the identification of new early bio-markers of cancer, including hepatocellular carcinoma. Nevertheless, the development of high-throughput diagnostic methods in this area is still in its infancy, and the design of new integrated technological solutions is of great interest and topicality. The main hypothesis of this study is that the development of a novel technology integrating resonant gold nanostructures in the mid-infrared can significantly contribute to the development of new approaches for the diagnosis of hepatocellular carcinoma.

Interventions

DIAGNOSTIC_TESTsierological test

sierological test: circulant vescicles

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion * 18 years old with a diagnosis of liver cirrhosis of different etiology * 18 years old with a diagnosis of hepatocellular carcinoma Exclusion * Have not signed the informed consent * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
primary endpoint12 monthsTo evaluate the change in extracellular vesicle concentration between the control group and oncology group. The concentration of vesicles per ml of blood will be measured by frequency shift of the plasmonic resonance peak of gold nanostructures following immuno-capture of vesicles.

Countries

Italy

Contacts

Primary ContactFABRIZIO PIZZOLANTE, MD PhD
fabrizio.pizzolante@policlinicogemelli.it+390630151
Backup ContactGabriele Ciasca, Professor
gabriele.ciasca@unicatt.it+390630151

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026